Concepedia

Chun-ling Dai

CD

Statistics

Publications

19

Citations

1.7K

H-Index

18

Active since

2007

Affiliations

Sun Yat-sen University(Current)

Sun Yat-sen University Cancer Center

St. John's University

State Key Laboratory of Oncology in South China

National Institutes of Health

Chun-ling Dai is an author at Sun Yat-sen University specializing in pharmacology, medicine, and chemotherapy.

Publications per year

2007–2015

19

Publications

19

Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2

Chun-ling Dai, Amit K. Tiwari, Chung‐Pu Wu et al. · Cancer Research · 2008 · 385 citations · Full text

, , +16

Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

Yan‐jun Mi, Yong‐ju Liang, Hong-Bing Huang et al. · Cancer Research · 2010 · 349 citations · Full text

, , +17

Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models

Amit K. Tiwari, Kamlesh Sodani, Chun-ling Dai et al. · Cancer Letters · 2012 · 140 citations

, , +11

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2

Chun-ling Dai, Yong‐ju Liang, Yan-sheng Wang et al. · Cancer Letters · 2009 · 118 citations

, , +8

Secalonic Acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathway

Jianye Zhang, Li-yang Tao, Yong‐ju Liang et al. · Cell Cycle · 2009 · 110 citations · Full text

, , +14

1–5 of 19